Cargando…
The Endocannabinoid System as a Therapeutic Target in Glaucoma
Glaucoma is an irreversible blinding eye disease which produces progressive retinal ganglion cell (RGC) loss. Intraocular pressure (IOP) is currently the only modifiable risk factor, and lowering IOP results in reduced risk of progression of the disorder. The endocannabinoid system (ECS) has attract...
Autores principales: | Cairns, Elizabeth A., Baldridge, William H., Kelly, Melanie E. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737462/ https://www.ncbi.nlm.nih.gov/pubmed/26881140 http://dx.doi.org/10.1155/2016/9364091 |
Ejemplares similares
-
The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies
por: Khayat, Wujood, et al.
Publicado: (2022) -
Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review
por: Steardo, Luca, et al.
Publicado: (2021) -
Modulation of the Endocannabinoid System Following Central Nervous System Injury
por: Zhou, Juan, et al.
Publicado: (2019) -
New paradigms for the treatment of lysosomal storage diseases: targeting the endocannabinoid system as a therapeutic strategy
por: Schuchman, Edward H., et al.
Publicado: (2021) -
The Endocannabinoid System as a Therapeutic Target in Diabetic Peripheral Neuropathic Pain: A Review
por: Bagher, Amina M.
Publicado: (2021)